북미의 OTC 히알루론산 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 판매 채널별, 국가별, 부문별 예측(2024-2030년)

North America OTC Hyaluronic Acid Market Growth & Trends:

The North America OTC hyaluronic acid market size is expected to reach USD 10.29 billion by 2030, registering a CAGR of 7.9% during the forecast period, according to a new report by Grand View Research, Inc. The increasing number of obese people owing to the lack of physical activity and higher consumption of fast food & alcohol, especially by the younger population are some of the factors accounting for growth.

Orthopedic applications of hyaluronic acid (HA) are expected to emerge as the most lucrative segment of this market. This can be attributed to the growing target audience above 60 years, suffering from various joint disorders such as rheumatoid arthritis and osteoarthritis coupled with the introduction of new products catering to this population subset. In addition, an increase in the number of arthritis-related hospitalization cases and growing awareness amongst the healthcare professionals regarding excellent physiochemical properties of hyaluronic acid is expected to drive the demand. The growing population of women between 20 and 65 years of age and increasing awareness regarding the benefits of HA is some of the crucial factors driving the surging demand for hyaluronic acid in dermatological procedures.

Hyaluronic acid (HA) stimulates the synthesis of a protein that plays a crucial role in supporting skin structure and collagen, which declines with age leading to wrinkling formation. The growing demand for HA as a topical skin cream or serum coupled with the increasing presence of market participants in this sector is indicative of future growth. The rising awareness regarding the benefits of HA in skincare products for penetrating the dermis more effectively as compared to collagen is also anticipated to propel the market trend. According to various reports, approximately 27% of the total U.S. women population belong to the age group of 45 to 65 years, which is one of the crucial factors responsible for the surging demand for anti-wrinkle creams.

Some of the key players are Shiseido Co., Ltd.; Lindberg Nutrition & GeniusCentral Systems; Nature's Way Products, LLC; NOW Foods; NeoCell Corporation; Source Naturals, Inc.; Doctors Best; derma e; and Earth Science Naturals.

North America OTC Hyaluronic Acid Market Report Highlights:

• By product, Dermatology segment accounted for the largest market revenue share in 2023. The rapid growth of this segment is being fueled by a surge in demand for HA-based fillers for various procedures, as well as a rise in cases of skin concerns such as wrinkles, acne, and scarring.
• Orthopedics is expected to register the fastest growth during the forecast period, driven by the rise of musculoskeletal disorders, sports injuries, and fractures.
• By sales channel, retail accounted for the largest market revenue share of 83.7% in 2023. Main factors that is anticipated to drive the market is the easy access to cosmetics and joint supplements in drug stores, departmental stores, and supermarkets.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. North America OTC Hyaluronic Acid Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. North America OTC Hyaluronic Acid Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. North America OTC Hyaluronic Acid Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. North America OTC Hyaluronic Acid Market: Product Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Dermatology
  • 4.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Moisturizers
    • 4.3.2.1. Moisturizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Anti-wrinkle Creme
    • 4.3.3.1. Anti-wrinkle Creme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Orthopedics
  • 4.4.1. Orthopedics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America OTC Hyaluronic Acid Market: Sales Channel Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. North America OTC Hyaluronic Acid Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Retail
  • 5.3.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Online
  • 5.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America OTC Hyaluronic Acid Market: Regional Estimates & Trend Analysis

• 6.1. North America OTC Hyaluronic Acid Market Share, By Country, 2023 & 2030 (USD Million)
• 6.2. U.S.
  • 6.2.1. U.S. OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. California
    • 6.2.2.1. California OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Texas
    • 6.2.3.1. Texas OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. New York
    • 6.2.4.1. New York OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.5. Florida
    • 6.2.5.1. Florida OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.6. Other States
    • 6.2.6.1. Other States OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Canada
  • 6.3.1. Canada North America OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Mexico
  • 6.4.1. Mexico North America OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Shiseido Company
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/Strategic Initiatives
  • 7.4.2. Lindberg Nutrition Products
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/Strategic Initiatives
  • 7.4.3. Nature's Way
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/Strategic Initiatives
  • 7.4.4. Now Foods
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/Strategic Initiatives
  • 7.4.5. NeoCell Corporation
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/Strategic Initiatives
  • 7.4.6. Source Naturals, Inc.
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/Strategic Initiatives
  • 7.4.7. Doctor's Best
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/Strategic Initiatives
  • 7.4.8. Derma E
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/Strategic Initiatives
  • 7.4.9. Earth Science
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/Strategic Initiatives